Researchers at the University of Pennsylvania School of Medicine have shown how Argos, a fruit fly protein, acts as a "decoy" receptor, binding growth factors that promote the progression of cancer.
Knowing how Argos neutralizes tumor growth may lead to new drug designs for inhibiting cancer.
Post new comment